These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30346564)

  • 1. Fractional dosing of yellow fever vaccine during shortages: perspective from Canada.
    Teitelbaum P; Bui YG; Libman M; McCarthy A
    J Travel Med; 2018 Jan; 25(1):. PubMed ID: 30346564
    [No Abstract]   [Full Text] [Related]  

  • 2. Yellow fever vaccine. WHO position paper.
    World Health Organization
    Wkly Epidemiol Rec; 2003 Oct; 78(40):349-59. PubMed ID: 14569711
    [No Abstract]   [Full Text] [Related]  

  • 3. Towards the risk of yellow fever transmission in Europe.
    Javelle E; Gautret P; Raoult D
    Clin Microbiol Infect; 2019 Jan; 25(1):10-12. PubMed ID: 30170135
    [No Abstract]   [Full Text] [Related]  

  • 4. The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever.
    Jentes ES; Poumerol G; Gershman MD; Hill DR; Lemarchand J; Lewis RF; Staples JE; Tomori O; Wilder-Smith A; Monath TP;
    Lancet Infect Dis; 2011 Aug; 11(8):622-32. PubMed ID: 21798462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can the safety of the yellow fever vaccine be evaluated by a retrospective study of databases?
    Thomas RE
    J Travel Med; 2013; 20(6):344-5. PubMed ID: 24165379
    [No Abstract]   [Full Text] [Related]  

  • 6. Is a dose of 17D vaccine in the current context of Yellow Fever enough?
    Estofolete CF; Nogueira ML
    Braz J Microbiol; 2018; 49(3):683-684. PubMed ID: 29588199
    [No Abstract]   [Full Text] [Related]  

  • 7. Fractional-dose yellow fever vaccination: how much more can we do with less?
    Visser LG
    Curr Opin Infect Dis; 2019 Oct; 32(5):390-393. PubMed ID: 31335440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What's Old Is New Again: The Re-emergence of Yellow Fever in Brazil and Vaccine Shortages.
    Chen LH; Kozarsky PE; Visser LG
    Clin Infect Dis; 2019 May; 68(10):1761-1762. PubMed ID: 30204852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yellow fever vaccination of human immunodeficiency virus-infected patients: report of 2 cases.
    Receveur MC; Thiébaut R; Vedy S; Malvy D; Mercié P; Bras ML
    Clin Infect Dis; 2000 Sep; 31(3):E7-8. PubMed ID: 11017859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WHO position on the use of fractional doses - June 2017, addendum to vaccines and vaccination against yellow fever WHO: Position paper - June 2013.
    World Health Organization
    Vaccine; 2017 Oct; 35(43):5751-5752. PubMed ID: 28689653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations for travellers during the yellow fever outbreaks in Brazil-2018.
    Fujita DM; da Silva Nali LH; Salvador FS; de Andrade Júnior HF
    J Travel Med; 2018 Jan; 25(1):. PubMed ID: 29635644
    [No Abstract]   [Full Text] [Related]  

  • 12. Travel characteristics and yellow fever vaccine usage among US Global TravEpiNet travelers visiting countries with risk of yellow fever virus transmission, 2009-2011.
    Jentes ES; Han P; Gershman MD; Rao SR; LaRocque RC; Staples JE; Ryan ET; The Global TravEpiNet Consortium
    Am J Trop Med Hyg; 2013 May; 88(5):954-961. PubMed ID: 23458961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yellow fever: epidemiology and prevention.
    Barnett ED
    Clin Infect Dis; 2007 Mar; 44(6):850-6. PubMed ID: 17304460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yellow Fever Vaccine Booster Doses: Recommendations of the Advisory Committee on Immunization Practices, 2015.
    Staples JE; Bocchini JA; Rubin L; Fischer M;
    MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(23):647-50. PubMed ID: 26086636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Notes from the Field: Investigation of Patients Testing Positive for Yellow Fever Viral RNA After Vaccination During a Mass Yellow Fever Vaccination Campaign - Angola, 2016.
    Boyd AT; Dombaxe D; Moreira R; Oliveira MS; Manuel E; Colorado CN; Lanzieri TM
    MMWR Morb Mortal Wkly Rep; 2017 Mar; 66(10):282-283. PubMed ID: 28301446
    [No Abstract]   [Full Text] [Related]  

  • 16. Yellow fever vaccine.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1984 Jan; 32(52):679-82, 687-8. PubMed ID: 6419048
    [No Abstract]   [Full Text] [Related]  

  • 17. Accumulating evidence on the long-term immunogenicity of fractional dosing for yellow fever vaccines.
    Juan-Giner A; Warimwe G
    Lancet Infect Dis; 2024 Jun; 24(6):562-564. PubMed ID: 38335975
    [No Abstract]   [Full Text] [Related]  

  • 18. Yellow Fever Vaccination of a Primary Vaccinee During Adalimumab Therapy.
    Nash ER; Brand M; Chalkias S
    J Travel Med; 2015; 22(4):279-81. PubMed ID: 25922988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yellow fever in Brazil: Epidemiological aspects and implications for travelers.
    Chaves TDSS; Orduna T; Lepetic A; Macchi A; Verbanaz S; Risquez A; Perret C; Echazarreta S; Rodríguez-Morales AJ; Lloveras SC
    Travel Med Infect Dis; 2018; 23():1-3. PubMed ID: 29751132
    [No Abstract]   [Full Text] [Related]  

  • 20. Vaccines and vaccination against yellow fever. WHO position paper -- June 2013.
    Wkly Epidemiol Rec; 2013 Jul; 88(27):269-83. PubMed ID: 23909008
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.